ciprofloxacin has been researched along with Acantholysis Bullosa in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Excerpt | Relevance | Reference |
---|---|---|
"Ciprofloxacin-resistant SA was found significantly predominant in chronic wounds (**P < ." | 1.91 | Longitudinal study of wound healing status and bacterial colonisation of Staphylococcus aureus and Corynebacterium diphtheriae in epidermolysis bullosa patients. ( Acevedo, F; Arancibia, E; Fuentes, I; Morandé, P; Oróstica, K; Palisson, F; Porte, L; Rebolledo-Jaramillo, B; Varela, C; Yubero, MJ, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Fuentes, I | 1 |
Yubero, MJ | 1 |
Morandé, P | 1 |
Varela, C | 1 |
Oróstica, K | 1 |
Acevedo, F | 1 |
Rebolledo-Jaramillo, B | 1 |
Arancibia, E | 1 |
Porte, L | 1 |
Palisson, F | 1 |
1 other study available for ciprofloxacin and Acantholysis Bullosa
Article | Year |
---|---|
Longitudinal study of wound healing status and bacterial colonisation of Staphylococcus aureus and Corynebacterium diphtheriae in epidermolysis bullosa patients.
Topics: Ciprofloxacin; Corynebacterium diphtheriae; Epidermolysis Bullosa; Epidermolysis Bullosa Dystrophica | 2023 |